Introduction
============

Glaucoma is one of the leading causes of irreversible blindness worldwide. It is a group of heterogeneous diseases characterized by progressive loss of retinal ganglion cells and degenerative optic neuropathy with or without elevated intraocular pressure (IOP) \[[@r1]\]. Open angle glaucoma is a major form of glaucoma and can be classified into primary open angle glaucoma (POAG) and secondary open angle glaucoma. Exfoliation glaucoma (XFG) is the most common form of secondary open angle glaucoma and is caused by obstruction of extracellular material in the anterior chamber angle in exfoliation syndrome (XFS), which is an age-related disease characterized by deposits of extracellular material in the anterior segment, including the cornea, lens, iris, and anterior chamber \[[@r2]\]. The prevalence of XFS varies widely across different ethnic populations. In people aged 60 or above, the prevalence of XFS is 0.4% in Hong Kong Chinese \[[@r3]\], 0.7% in Singapore Chinese \[[@r4]\], 4.4% in Japanese \[[@r5]\], and 10%--20% in the Caucasian population \[[@r6]\].

The etiology and pathogenesis of glaucoma are complex and involve multiple genetic and environmental factors. Myocilin (*MYOC*) is a causative gene for POAG and cytochrome P450, 1B1 (*CYP1B1*) for congenital glaucoma \[[@r7],[@r8]\]. Mutations in optineurin (*OPTN*) and WD repeat domain 36 (*WDR36*) do not directly lead to POAG but increase the risk \[[@r9],[@r10]\]. As for XFS and XFG, significant association with three single nucleotide polymorphisms (SNPs), [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661), [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241), and [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942), in the *Lysyl oxidase-like 1* (*LOXL1*) gene was first discovered in 2007 in Icelandic and Swedish populations by a genome-wide association study \[[@r11]\]. SNP [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) was marginally (p=0.04) associated with POAG in the Icelandic but not in the Swedish population, while [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) and [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) were not associated with POAG in either population \[[@r11]\].

Since then the association of *LOXL1* SNPs with XFS/XFG has been reported in Caucasian populations in the USA \[[@r12]-[@r16]\], Australia \[[@r17]\], Austria \[[@r18]\], Germany \[[@r19],[@r20]\], Italy \[[@r20]\], and Finland \[[@r21]\] and in other ethnic groups, including Japanese \[[@r22]-[@r27]\], Indian \[[@r28]\], and Chinese \[[@r29],[@r30]\]. *LOXL1* SNPs in POAG have also been studied in Caucasian \[[@r14],[@r21],[@r31]\], Japanese \[[@r22],[@r24],[@r27]\], Chinese \[[@r32]\], Indian \[[@r33]\], and African populations \[[@r31]\]. Other types of glaucoma, such as normal tension glaucoma and pigmentary glaucoma, have been investigated in India \[[@r33]\], Japan \[[@r27]\], Germany \[[@r19]\], and the USA \[[@r34]\]. Despite the large amount of information, the overall association of SNPs and the discrepancies between individual cohorts or subgroups remain to be characterized.

Meta-analysis is a very useful statistical tool not only to summarize data from individual studies concerning a specific research question but also to identify and analyze the consistency and discrepancies of individual studies or population subgroups. The prevalence of XFS/XFG varies widely among different ethnic populations mainly due to variations in genetic background. Therefore, to ascertain effects due to ethnic differences, meta-analysis of the genetic association of *LOXL1* SNPs with glaucoma could be performed based on subgrouping by ethnicity. In *LOXL1*, three SNPs ([rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661), [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241), and [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942)) were first found associated with XFS/XFG in Icelandic and Swedish populations. They appeared in most of the reported studies, despite some inconsistencies in their presence \[[@r16],[@r24],[@r29],[@r31]\]. Several other SNPs at *LOXL1* ([rs12437465](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=12437465), [rs2304719](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2304719), and [rs3522](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3522)) have also been reported \[[@r13],[@r17],[@r31]\], but their associations were due to intermarker linkage disequilibrium (LD) and limited functional studies of these SNPs were reported, so they were not included in this meta-analysis. In this study, we perform a subgroup based meta-analysis using all of the reported studies on the association of *LOXL1* SNPs ([rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661), [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241), and [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942)) with XFS, XFG, and POAG.

Methods
=======

An internet-based literature search was conducted on [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/) and [Embase](http://www.embase.com), using the search strategy ("LOXL1" OR "LOXL" OR "Lysyl oxidase-like") AND ("glaucoma" OR "exfoliation" OR "pseudoexfoliation"). The cut-off date was December 12, 2009. In total 41 articles were obtained from PubMed and 38 from Embase. Articles meeting the following criteria were included for further data analysis: (1) case-control study, cohort study, or population-based epidemiological survey; (2) reports on the association of three SNPs in *LOXL1*, i.e., [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661), [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241), and/or [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942), with XFS, XFG, POAG, or/and other types of glaucoma; (3) studies with reported and accessible sample size, allele, and/or genotype frequencies/counts in both patients and controls; and (4) original research articles, not reviews or comments. Repetitive publications, which were ruled out through tracking references, were incorporated as the latest reports. If several different cohorts were reported in the same article, they were treated as independent studies.

The retrieved abstracts and full texts were separately reviewed by two investigators (H.Y.C. and W.F.G.) who also independently performed data extraction and quality evaluation. A third reviewer (L.J.C.) would participate in the review if there was disagreement in the retrieved information. Total consensus of the three reviewers needed to be obtained on all retrieved data. The ethnicity, sample size, age, sex, allele, and/or genotype frequency/counts in both patients and controls were recorded. For studies with no direct data of genotype or allele counts, we calculated the frequency according to the reported data, rounding to the closest integer. The allele counting was also calculated from genotype counting when needed.

The Review Manager (version 5.0.18; The Cochrane Collaboration, Copenhagen, Denmark and SPSS software (ver. 16.0; SPSS Inc., Chicago, IL) were used to perform the meta-analysis: (1) The Hardy--Weinberg equilibrium (HWE) of each SNP in the control group of each study was examined by using χ^2^ analysis; (2) meta-analysis of the *LOXL1* SNPs [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661), [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241), and [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) was performed to compare the allelic distributions between XFS and XFG; (3) if there were no statistical differences in allelic distributions between XFS and XFG, these two groups were combined. Meta-analyses of the allelic associations of [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661), [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241), and [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) with overall XFS and XFG were performed; (4) if positive results were obtained from allelic association analysis, genotypic association analyses were performed using different genetic models, including multiplicative models estimating the homozygous odds ratio (OR) and heterozygous OR as well as the dominant model and recessive model; and (5) the allele association of [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661), [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241), and [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) with POAG was analyzed. All the meta-analyses were performed in subgroupings by ethnicity. In all of the meta-analyses, the ORs were estimated by the fixed or random model according to the heterogeneity test. When the heterogeneity test α was \<0.1, a random model was applied, and when the heterogeneity test α was \>0.1, a fixed model was applied. Sensitivity tests were performed, but studies with counting data that were computed from frequencies data were excluded.

Results
=======

There were 20 articles reporting the association of *LOXL1* SNPs with XFS/XFG in a total of 3,068 cases and 20,363 controls from 22 study cohorts ([Table 1](#t1){ref-type="table"}). Nine articles investigated the association between *LOXL1* SNPs and POAG in a total of 2,223 POAG patients and 16,664 controls from 13 cohorts ([Table 2](#t2){ref-type="table"}). The HWE of all three SNPs was tested in the control groups of all cohorts. No deviation from the HWE was identified.

###### Characters of reported cohorts of pseudoexfoliation syndrome/exfoliation glaucoma association with *LOXL1* SNPs

  **First author**   **Cohorts**   **Sample size**   **Age (years)**   **Sex (Male %)**   [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) **G%**   [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) **T%**   [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) **G%**   **Ref**                                      
  ------------------ ------------- ----------------- ----------------- ------------------ ---------------------------------------------------------------------------- ---------------------------------------------------------------------------- ---------------------------------------------------------------------------- --------- ------ ------ ------ ------ ------ ------------
  Aragon-Martin      American      287               333               NA                 NA                                                                           NA                                                                           NA                                                                           84.3      70.3   73.4   44.8   95.9   79.8   \[[@r12]\]
  Challa\*           American      50                235               74.0±8.0           64.9±11.6                                                                    78.0                                                                         61.7                                                                         78.7      66.5   66.7   48.7   93.9   84.4   \[[@r13]\]
  Fan                American      206               88                75                 72                                                                           NA                                                                           43                                                                           82.9      71.9   76.0   45.6   98.8   79.5   \[[@r14]\]
  Fingert            American      72                75                NA                 NA                                                                           NA                                                                           NA                                                                           81.9      60.0   NA     NA     98.6   88.0   \[[@r15]\]
  Yang               American      62                170               NA                 74.2±8.8                                                                     38.7                                                                         52.9                                                                         NA        NA     83     53     100    85     \[[@r16]\]
  Hewitt\*           Australian    86                2087              76.4±8.1           68.6±10.0                                                                    37.2                                                                         44.8                                                                         78        66     NA     NA     95     84     \[[@r17]\]
  Mossbock           Austrian      167               170               75.7               77.1                                                                         45.5                                                                         44.1                                                                         84.1      67.1   NA     NA     99.4   81.7   \[[@r18]\]
  Wolf               Germany       128               280               71.9±9.7           66±13                                                                        44                                                                           41                                                                           84.4      66.0   78.2   49.1   99.2   85.6   \[[@r19]\]
  Pasutto            Germany       517               348               76.6±8.5           73.9±6.4                                                                     44.5                                                                         43.4                                                                         81.8      64.4   75.2   48.2   95.1   85.7   \[[@r20]\]
  Pasutto            Italian       209               70                78.3±7.7           75.2±7.4                                                                     39.2                                                                         35.7                                                                         82.5      69.3   79.8   51.5   100    82.1   \[[@r20]\]
  Thorleifsson       Icelandian    130               14474             NA                 NA                                                                           NA                                                                           NA                                                                           78.1      65.1   74.6   47.3   98.4   84.7   \[[@r11]\]
  Thorleifsson       Swedish       199               198               NA                 NA                                                                           NA                                                                           NA                                                                           83.4      68.2   81.3   53.5   99.5   87.9   \[[@r11]\]
  Lemmela            Finnish       141               404               NA                 NA                                                                           NA                                                                           NA                                                                           82.5      68.3   73.2   46.8   96.8   82.3   \[[@r21]\]
  Ramprasad          Indian        52                97                68.9±11.4          64.1±7.2                                                                     51.9                                                                         53.6                                                                         72.1      63.4   NA     NA     92.3   74.2   \[[@r28]\]
  Lee                Chinese       62                171               74.7±7.7           67.4±5.6                                                                     48.4                                                                         46.8                                                                         54.2      44.4   NA     NA     99.2   91.8   \[[@r29]\]
  Chen               Chinese       50                124               70.4±7.6           63.8±5.1                                                                     62.0                                                                         57.6                                                                         11.0      48.0   2.0    10.0   100    90.0   \[[@r30]\]
  Fuse               Japanese      56                138               74.8±6.2           68.0±7.7                                                                     55.4                                                                         55.1                                                                         3.6       49.3   1.8    5.8    100    87.7   \[[@r22]\]
  Hayashi            Japanese      59                190               78.4±6.9           31.4±1.5                                                                     37.3                                                                         50.0                                                                         0.8       46.0   NA     NA     100    85.7   \[[@r23]\]
  Mabuchi            Japanese      89                191               76.5±6.6           65.7±11.4                                                                    NA                                                                           NA                                                                           0.6       45.0   NA     NA     99.4   85.3   \[[@r24]\]
  Mori               Japanese      95                190               75.7±8.1           65.0±6.8                                                                     NA                                                                           NA                                                                           0.5       47.4   NA     NA     99.5   85.0   \[[@r25]\]
  Ozaki              Japanese      209               172               78.0±6.1           73.8±7.9                                                                     32.1                                                                         27.9                                                                         5.3       49.7   1.7    10.2   98.6   86.3   \[[@r26]\]
  Tanito             Japanese      142               157               78.5±8.2           77.2±5.0                                                                     38.0                                                                         28.7                                                                         4.9       55.4   0.7    12.4   99.3   80.6   \[[@r27]\]

The asterisk indicates the counting data was calculated from rate data. NA: data not available. Ref: references.

###### Characters of reported cohorts of primary open angle glaucoma association with *LOXL1* SNPs

  **First author**   **Cohorts**        **Sample size**   **Age (years±SD)**   **Sex (Male %)**   [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) **G%**   [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) **T%**   [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) **G%**   **Ref**                                      
  ------------------ ------------------ ----------------- -------------------- ------------------ ---------------------------------------------------------------------------- ---------------------------------------------------------------------------- ---------------------------------------------------------------------------- --------- ------ ------ ------ ------ ------ ------------
  Fan                American           331               88                   75                 72                                                                           NA                                                                           43.2                                                                         72.4      71.9   41.2   45.6   77.1   79.5   \[[@r14]\]
  Thorleifsson       Icelandian         90                14474                NA                 NA                                                                           NA                                                                           NA                                                                           71.1      65.1   55.0   47.3   87.2   84.7   \[[@r11]\]
  Thorleifsson       Swedish            200               198                  NA                 NA                                                                           NA                                                                           NA                                                                           63.8      68.2   48.8   53.3   86.3   87.9   \[[@r11]\]
  Lemmela            Finnish            71                404                  NA                 NA                                                                           NA                                                                           NA                                                                           69.4      68.3   45.7   46.8   78.7   82.3   \[[@r21]\]
  Liu\*              Caucasian          279               227                  58.7±12.8          \>55                                                                         NA                                                                           NA                                                                           NA        NA     42.4   48.6   82.9   84.4   \[[@r31]\]
  Liu\*              African American   193               97                   55.3±13.3          \>55                                                                         NA                                                                           NA                                                                           NA        NA     23.7   20.4   61.7   59.9   \[[@r31]\]
  Liu\*              Ghanaian           170               138                  55.4±13.8          \>55                                                                         NA                                                                           NA                                                                           NA        NA     22.6   19.3   62.2   57.0   \[[@r31]\]
  Chakrabarti\*      Indian             112               105                  NA                 NA                                                                           NA                                                                           NA                                                                           61.6      69.5   32.1   32.0   83.0   75.0   \[[@r33]\]
  Fuse               Japanese           62                138                  NA                 68.0±7.7                                                                     NA                                                                           55.1                                                                         39.5      49.3   4.8    5.8    91.1   87.7   \[[@r22]\]
  Mabuchi            Japanese           213               191                  62.9±14.8          65.7±11.4                                                                    NA                                                                           NA                                                                           47.2      45.0   NA     NA     85.0   85.3   \[[@r25]\]
  Tanito             Japanese           40                157                  75.6±5.3           77.2±5.0                                                                     35.0                                                                         28.7                                                                         51.3      55.4   3.8    12.4   80.0   80.6   \[[@r27]\]
  Gong               Southern Chinese   293               250                  66.8±12.9          74.1±6.8                                                                     60.1                                                                         49.2                                                                         42.0      47.2   8.4    10.2   89.4   87.6   \[[@r32]\]
  Gong               Northern Chinese   169               197                  39.1±16.5          69.4±6.0                                                                     78.1                                                                         49.2                                                                         47.9      49.7   8.6    8.4    89.9   86.5   \[[@r32]\]

The asterisk indicates the counting data was estimated from frequency data. NA: data not available. Ref: references

There was no significant difference in allele frequencies between XFS and XFG for [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) and [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) in any cohort. The overall OR for the two SNPs was 1.15 (95% confidence interval \[CI\] 0.95--1.39, p=0.15, [Figure 1](#f1){ref-type="fig"}) and 1.15 (95% CI 0.97--1.37, p=0.10, [Figure 2](#f2){ref-type="fig"}), respectively. The OR due to [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) could not be estimated in four out of the 11 cohorts due to 100% G allele frequencies occurring in both the XFS and XFG groups. Therefore, we calculated the risk difference instead of the OR. The risk difference between XFS and XFG was 0.01 (95% CI −0.00--0.02, p=0.20, [Figure 3](#f3){ref-type="fig"}), and showed no statistically significant difference in the distributional profiles of the three SNPs between XFS and XFG. We thus combined the XFS and XFG groups in subsequent analyses.

![Meta-analysis of the distribution of single nucleotide polymorphism (SNP) [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) between exfoliation syndrome (XFS) and exfoliation glaucoma (XFG). Squares indicate study-specific odds ratio (OR); the size of the box is proportional to the weight of the study; horizontal lines indicate 95% confidence interval (CI); diamond indicates summary OR with its corresponding 95% CI. Meta-analysis indicated there is no statistical difference of distribution of the SNP [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) G and T allele between XFS and XFG.](mv-v16-167-f1){#f1}

![Meta-analysis of the distribution of single nucleotide polymorphism (SNP) [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) between exfoliation syndrome (XFS) and exfoliation glaucoma (XFG). Squares indicate study-specific odds ratio (OR); the size of the box is proportional to the weight of the study; horizontal lines indicate 95% confidence interval (CI); diamond indicates summary OR with its corresponding 95% CI. Meta-analysis indicated there is no statistical difference of distribution of the SNP [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) T and C allele between XFS and XFG.](mv-v16-167-f2){#f2}

![Meta-analysis of the distribution of single nucleotide polymorphism (SNP) [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) between exfoliation syndrome (XFS) and exfoliation glaucoma (XFG). Squares indicate study-specific risk difference (RD); the size of the box is proportional to the weight of the study; horizontal lines indicate 95% confidence interval (CI); diamond indicates summary RD with its corresponding 95% CI. Meta-analysis indicated there is no statistical difference of distribution of the SNP [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) G and A allele between XFS and XFG.](mv-v16-167-f3){#f3}

Moreover, the association profiles of *LOXL1* SNPs were examined by comparing the patients with XFS or XFG versus control subjects in different populations. The study cohorts were from four major ethnic groups: Caucasian, Japanese, Chinese, and Indian. In most individual studies, significant allelic association was found between XFS/XFG and the *LOXL1* SNPs [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661), [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241), and [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942), regardless of ethnicity. In the association of [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) with XFS/XFG, the ORs of the G allele in every study was significantly greater than 1 and the ORs lay on the same side of the *y*-axis. The OR was 9.30 (95% CI 5.70--15.16, p\<0.00001) in Caucasian, 18.72 (95% CI 10.07--34.79, p\<0.00001) in Japanese, 14.23 (95% CI 2.78--72.79, p=0.001) in Chinese, and 4.17 (95% CI 7.04--16.55, p=0.0004) in Indian populations. The overall OR was 10.89 (95% CI 7.20--16.45, p\<0.00001) for the four ethnic populations ([Figure 6](#f6){ref-type="fig"}). Notably, however, the ORs of [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) in Caucasian and Japanese populations were reversed. OR for the T allele was 3.39 (95% CI 3.07--3.74, p\<0.00001) in Caucasian populations, suggesting that the T allele was the at-risk allele. The OR for the T allele was 0.13 (95% CI 0.06--0.32, p\<0.00001) in Japanese populations, indicating that the T allele was a protective allele ([Figure 5](#f5){ref-type="fig"}). Such discrepancy was also observed in [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661), with OR for the G allele being 2.35 (95% CI 2.12--2.60, p\<0.00001) in Caucasian, and 0.03 (95% CI 0.01--0.06, p\<0.00001) in Japanese populations but not significant in Chinese and Indian populations ([Figure 4](#f4){ref-type="fig"}). Sensitivity tests were subsequently performed. Cohorts whose allele counting data were calculated from the frequencies data, Challa's Duke (US) cohort \[[@r13]\] and Hewitt's Austrian cohort \[[@r17]\], were removed. The OR for the rs3825942 G allele was 9.30 and 12.40 in Caucasians before and after removing the two cohorts, respectively. The OR for the [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) G allele was 2.35 and 2.41 in Caucasians before and after removing the two cohorts, respectively. The OR for the [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) T allele was 3.39 and 3.47 in Caucasians before and after removing the two cohorts, respectively.

![Meta-analysis of the association of single nucleotide polymorphism (SNP) [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) with a combined group of exfoliation syndrome (XFS) and exfoliation glaucoma (XFG). Squares indicate study-specific odds ratio (OR); the size of the box is proportional to the weight of the study; horizontal lines indicate 95% confidence interval (CI); diamond indicates summary OR with its corresponding 95% CI. Subgroup meta-analysis indicated that the ORs SNP [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) G allele is consistent in Caucasian and Japanese.](mv-v16-167-f6){#f6}

![Meta-analysis of the association of single nucleotide polymorphism (SNP) [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) with a combined group of exfoliation syndrome (XFS) and exfoliation glaucoma (XFG). Squares indicate study-specific odds ratio (OR); the size of the box is proportional to the weight of the study; horizontal lines indicate 95% confidence interval (CI); diamond indicates summary OR with its corresponding 95% CI. Subgroup meta-analysis indicated that the ORs of SNP [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) T allele are reversed in Caucasian and Japanese.](mv-v16-167-f5){#f5}

![Meta-analysis of the association of single nucleotide polymorphism (SNP) [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) with a combined group of exfoliation syndrome (XFS) and exfoliation glaucoma (XFG). Squares indicate study-specific odds ratio (OR); the size of the box is proportional to the weight of the study; horizontal lines indicate 95% confidence interval (CI); diamond indicates summary OR with its corresponding 95% CI. Subgroup meta-analysis indicated that the ORs of SNP [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) G allele are reversed in Caucasian and Japanese.](mv-v16-167-f4){#f4}

Since the associations of [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) and [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) are inconsistently reported between Caucasian and Japanese populations, we performed genotype association analysis using different hereditary models only for [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942). When using a multiplicative/additive model, the total OR for the homozygous at-risk genotype (GG versus AA) was 9.06 (95% CI 5.16--15.92, p\<0.00001, [Figure 7](#f7){ref-type="fig"}), whereas the total OR for the heterozygous genotype (GA versus AA) was not significantly different from 1 (total OR=1.39, 95% CI 0.73--2.62, p=0.31, [Figure 8](#f8){ref-type="fig"}). On the other hand, the total OR was 7.05 (95% CI 4.03--12.34, p\<0.00001, [Figure 9](#f9){ref-type="fig"}) under the dominant model and 14.70 (95% CI 8.97--24.20, p\<0.00001, [Figure 10](#f10){ref-type="fig"}) under a recessive model. By subgroup-based meta-analysis, the ORs in different ethnic groups were comparable as the 95% CIs partially overlapped.

![Meta-analysis of the association of single nucleotide polymorphism (SNP) [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) with a combined group of exfoliation syndrome (XFS) and exfoliation glaucoma (XFG) in additive models. Squares indicate study-specific odds ratio (OR); the size of the box is proportional to the weight of the study; horizontal lines indicate 95% confidence interval (CI); diamond indicates summary OR with its corresponding 95% CI. Synthesized homozygous OR (GG versus AA) of SNP [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) was 9.06 for XFS/XFG.](mv-v16-167-f7){#f7}

![Meta-analysis of the association of single nucleotide polymorphism (SNP) [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) with a combined group of exfoliation syndrome (XFS) and exfoliation glaucoma (XFG) in additive models. Squares indicate study-specific odds ratio (OR); the size of the box is proportional to the weight of the study; horizontal lines indicate 95% confidence interval (CI); diamond indicates summary OR with its corresponding 95% CI. Meta-analysis indicated that the heterozygote genotype (GA) does have higher susceptibility to XFS/XFG compared to AA genotype. **C**: Synthesized OR of SNP [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) was 7.05 for XFS/XFG with dominant model (GG+GA versus AA).](mv-v16-167-f8){#f8}

![Meta-analysis of the association of single nucleotide polymorphism (SNP) [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) with a combined group of exfoliation syndrome (XFS) and exfoliation glaucoma (XFG) in dominant models. Squares indicate study-specific odds ratio (OR); the size of the box is proportional to the weight of the study; horizontal lines indicate 95% confidence interval (CI); diamond indicates summary OR with its corresponding 95% CI. Synthesized OR of SNP [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) was 7.05 for XFS/XFG with dominant model (GG+GA versus AA).](mv-v16-167-f9){#f9}

![Meta-analysis of the association of single nucleotide polymorphism (SNP) [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) with a combined group of exfoliation syndrome (XFS) and exfoliation glaucoma (XFG) in recessive models. Squares indicate study-specific odds ratio (OR); the size of the box is proportional to the weight of the study; horizontal lines indicate 95% confidence interval (CI); diamond indicates summary OR with its corresponding 95% CI. Synthesized OR of SNP [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) was 14.70 for XFS/XFG with recessive model (GG versus AA+GA).](mv-v16-167-f10){#f10}

There was no single article reporting a significant difference in allele distributions of [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) and [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) between POAG patients and control subjects. Our meta-analysis also identified no significant association between SNP [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) or [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) and POAG in any subgroup or the entire study populations. The overall OR was 0.93 (95% CI 0.84--1.03, p=0.16) for the G allele of [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) ([Figure 11](#f11){ref-type="fig"}) and 1.06 (95% CI 0.94--1.19, p=0.34) for the G allele of [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) ([Figure 13](#f13){ref-type="fig"}). By contrast, two out of the 12 cohorts reported significant association between [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) and POAG in Caucasian and Japanese populations. However, their ORs were in opposite directions, and the overall OR of the 12 studies was 0.95 (95% CI 0.82--1.10, p=0.50) for the T allele of [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) ([Figure 12](#f12){ref-type="fig"}). Sensitivity tests were performed in that the cohorts whose allele counting data were calculated from frequency data, Liu's Caucasian and African cohorts \[[@r31]\] and Chakrabarti's Indian cohort \[[@r33]\], were removed; however, the results were similar. None of the overall ORs were significantly different from 1 without the two cohorts. Since there was no significant allelic association between the three SNPs and POAG, no further meta-analysis (e.g., genotypic association) was performed.

![Meta-analysis of the association of single nucleotide polymorphism (SNP) [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) with primary open angle glaucoma (POAG). Squares indicate study-specific odds ratio (OR); the size of the box is proportional to the weight of the study; horizontal lines indicate 95% confidence interval (CI); diamond indicates summary OR with its corresponding 95% CI. Meta-analysis indicated there is no statistical significant association of SNP [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) with POAG.](mv-v16-167-f11){#f11}

![Meta-analysis of the association of single nucleotide polymorphism (SNP) [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) with primary open angle glaucoma (POAG). Squares indicate study-specific odds ratio (OR); the size of the box is proportional to the weight of the study; horizontal lines indicate 95% confidence interval (CI); diamond indicates summary OR with its corresponding 95% CI. Meta-analysis indicated there is no statistical significant association of SNP [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) with POAG.](mv-v16-167-f13){#f13}

![Meta-analysis of the association of single nucleotide polymorphism (SNP) [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) with primary open angle glaucoma (POAG). Squares indicate study-specific odds ratio (OR); the size of the box is proportional to the weight of the study; horizontal lines indicate 95% confidence interval (CI); diamond indicates summary OR with its corresponding 95% CI. Meta-analysis indicated there is no statistical significant association of SNP [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) with POAG.](mv-v16-167-f12){#f12}

Apart from XFS/XFG and POAG, there was also one study reporting the *LOXL1* SNPs in primary angle closure glaucoma (PACG), two in normal tension glaucoma (NTG), and two in pigment dispersion syndrome and pigmentary glaucoma. However, none of these studies identified a significant association between the *LOXL1* SNPs and these subtypes of glaucoma ([Table 3](#t3){ref-type="table"}). In our meta-analysis to investigate the association of *LOXL1* SNPs with NTG and PG, no statistical significant association was found (all p\>0.05).

###### Characters of reported cohorts of other ocular diseases association with *LOXL1* SNPs.

  **First author**   **Cohort**   **Disease**   **Sample size**   **Age (years±SD)**   **Sex (Male %)**   [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) **G**   [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) **T**   [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) **G**   **Ref**                                      
  ------------------ ------------ ------------- ----------------- -------------------- ------------------ --------------------------------------------------------------------------- --------------------------------------------------------------------------- --------------------------------------------------------------------------- --------- ------ ------ ------ ------ ------ ------------
  Chbakrabarti       Indian       PACG          96                105                  NA                 NA                                                                          NA                                                                          NA                                                                          65.6      69.0   30.2   31.9   76.6   74.8   \[[@r33]\]
  Tanito             Japanese     NTG           54                157                  78.3±4.8           77.2±5.1                                                                    33.3                                                                        28.7                                                                        53.7      55.4   13.9   12.4   79.6   80.6   \[[@r27]\]
  Wolf               Germany      NTG           273               280                  63.9±14.2          66±13                                                                       35                                                                          41                                                                          65.3      66.0   48.9   49.1   85.3   84.6   \[[@r19]\]
  Wolf               Germany      PG            88                280                  53.8±13.5          66±13                                                                       72                                                                          41                                                                          63.1      66.0   48.8   49.1   88.1   84.6   \[[@r19]\]
  Rao                American     PG            44                108                  NA                 NA                                                                          NA                                                                          NA                                                                          67.9      72.4   52.4   47.1   86.6   82.2   \[[@r34]\]
  Rao                American     PDS           34                108                  NA                 NA                                                                          NA                                                                          NA                                                                          66.7      72.4   50.0   47.1   83.3   82.2   \[[@r34]\]

NA: data not available. Ref: references. NTG: normal tension glaucoma. PACG: primary angle closure glaucoma; PG: pigmentary glaucoma. PDS: pigment dispersion syndrome.

Discussion
==========

Exfoliation glaucoma (XFG), a consequence of exfoliation syndrome (XFS), is the most common form of secondary open angle glaucoma. Approximately 25% patients with XFS present with increased IOP, and one-third have developed glaucoma \[[@r19]\]. To date, association of SNPs in the *LOXL1* gene with XFS and/or XFG has been shown across different populations; however, there were several different phenotypes in these studies. Thus, it is necessary to test whether XFS and XFG are of genetic homogeneity. In the first part of this present meta-analysis, the distribution profiles of the *LOXL1* SNPs between XFS and XFG were evaluated. By reviewing all the reported association profiles with meta-analysis, no statistical difference in any population group or overall study subjects was identified for any of the three SNPs ([rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661), [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241), and [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942)). All the p values were \>0.05.

Since *LOXL1* SNPs are not heterogenic in XFS and XFG, we combined these two phenotypes in our analysis. Our results also suggested that the *LOXL1* gene may contribute to disease onset of the exfoliation disease rather than just increased IOP. However, the current meta-analysis cannot prove this hypothesis because the data are from retrospective case-control studies. Further prospective longitudinal studies are warranted.

In most reported studies on *LOXL1* and XFS/XFG, the three SNPs ([rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661), [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241), and [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942)) have been investigated together \[[@r11]-[@r23],[@r25]-[@r28]\]. They are in strong LD among different populations. The haplotype defined by these SNPs was also significantly associated with the disease \[[@r11],[@r13],[@r20],[@r26],[@r28]\]. So far, however, there is no consolidated evidence to show which SNP plays a more major role in the molecular pathogenesis of XFS/XFG. On the other hand, the allelic and genotypic distributions of the three SNPs were found to be drastically different among different populations \[[@r11]-[@r23],[@r25]-[@r28]\]. Genetic diversity occurs across different ethnicities \[[@r35],[@r36]\]. Therefore, we resolved to find out which SNP plays a role across different populations. In the first part of our meta-analysis, we identified genetic homogeneity of the *LOXL1* SNPs between XFS and XFG. Therefore, the two disease groups were combined in the second part of the meta-analysis of genetic association in subpopulations. We found that the distribution was similar within each individual ethnic group for all three SNPs, [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661), [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241), and [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942). However, the allelic distributions of Japanese and Caucasian populations are reversed for [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) and [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241). The T allele of [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) and the G allele of [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) are the at-risk alleles in Caucasians, with an OR of 3.39 and 2.35, respectively. In contrast, the two alleles are protective in the Japanese population, with an OR of 0.13 and 0.03, respectively. All the ORs are statistically significant with p values \<0.00001. Therefore, it is more likely that SNPs [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) and [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) are not directly implicated in the pathogenesis of XFS/XFG. In contrast, the distribution of SNP [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) followed a similar pattern in all three ethnic groups. The G allele was the at-risk allele, and the OR was 9.30, 18.72, 10.97, and 4.17 in Caucasian, Japanese, Chinese and Indian populations, respectively. The total OR was 10.75 (95% CI 7.08--16.31). Our finding suggests that [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) is the common disease-associated polymorphism across different populations and may have functional impacts on the LOXL1 protein and contribute to the pathogenesis of XFS/XFG. Moreover, in the third part of this meta-analysis, we found that the OR for the homozygous genotype of [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) is 9.42, while the OR for the heterozygote is not statistically significant. Moreover, the OR in the recessive model was the highest among different genetic models (OR=14.55). Therefore, it could be inferred that [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) plays a role in a recessive pattern; however, what functional role [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) played in the pathogenesis of XFS/XFG remains unclear. *LOXL1* is located in 15q22, encoding a member of the lysyl oxidase family. The LOXL family is an extracellular copper-dependent amine oxidase that involved in the first step of the formation of cross-links in collagen and elastin. Therefore, sequence variation in *LOXL1* may influence the function, synthesis, and subsequent deposition of the extracellular tissues \[[@r37]\]. SNP [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) is located in the first exon of *LOXL1* and leads to a nonsynonymous amino acid change from glycine to asparagine at position 153 (G153D). However, functional prediction using in silico programs Polymorphism Phenotyping ([PolyPhen](http://genetics.bwh.harvard.edu/pph/)) and Sorting Intolerant From Tolerant ([SIFT](http://sift.jcvi.org/)) suggested that the amino acid substitution is benign and tolerated (data not shown). The exact functional effects of this substitution remain to be further investigated.

The association of *LOXL1* SNPs with other types of glaucoma, including POAG, NTG, pigmentary glaucoma, and PACG, were reviewed in this meta-analysis. However, no significant association was found between POAG and *LXOL1* SNPs after merging the results from 13 cohorts. Therefore, it is likely that *LOXL1* is not implicated in the primary open angle glaucomatous mechanism. Associations between *LXOL1* SNPs and NTG, pigmentary glaucoma, or PACG were also negative, although the number of articles included in this meta-analysis was limited. The lack of association between *LOXL1* and primary glaucoma has provided evidence supporting that *LOXL1* is linked to the pathogenesis of the exfoliation syndrome but not the direct genetic cause of IOP elevation and subsequent glaucoma.

In summary, by using meta-analysis the genetic homogeneity of *LOXL1* between XFS and XFG has been confirmed. The genetic effect of [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) is similar in different populations in a recessive genetic model. We detected inconsistencies in the effect of [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) and [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) between Caucasian and Japanese populations. Our results also revealed that the *LOXL1* gene is not a susceptibility gene of other types of glaucoma other than XFG. Further genetic studies are required to unravel the discrepancy in LD patterns of the *LOXL1* gene among different populations.

We thank the grant support to Haoyu Chen: National Natural Science Foundation of China (30901646), Science and Technology Project of Shantou City (2009--70). Portions of the data in this manuscript were presented at the 24th Asia Pacific Academy of Ophthalmology Association Congress (2009) in a poster presentation and at the 14th Congress of the Chinese Ophthalmological Society (2009) in a poster presentation.
